Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-23
2011-08-23
Saeed, Kamal (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S438000, C514S461000, C514S573000, C548S253000, C549S079000, C549S498000, C562S503000
Reexamination Certificate
active
08003680
ABSTRACT:
Disclosed herein are compounds of the formulatherapeutic methods, compositions, and medicaments related thereto are also disclosed.
REFERENCES:
patent: 3980700 (1976-09-01), Miyano
patent: 4073799 (1978-02-01), Kondo et al.
patent: 4094886 (1978-06-01), Kondo et al.
patent: 6531485 (2003-03-01), Cameron et al.
patent: 7405240 (2008-07-01), Old et al.
patent: 7429669 (2008-09-01), Old et al.
patent: 7507817 (2009-03-01), Old et al.
patent: 7605178 (2009-10-01), Old et al.
patent: 7635716 (2009-12-01), Old et al.
patent: 2003/0008895 (2003-01-01), Cameron et al.
patent: 2010/0029735 (2010-02-01), Old et al.
patent: 2359955 (1975-06-01), None
patent: 2608116 (1976-11-01), None
patent: 2708871 (1977-10-01), None
patent: 180705 (1983-04-01), None
patent: 191196 (1987-01-01), None
patent: 51-110557 (1976-09-01), None
patent: 4-149153 (1992-05-01), None
patent: 2001-163779 (2001-06-01), None
patent: WO02/26704 (2002-04-01), None
patent: WO2005/026109 (2005-03-01), None
patent: WO2006/112742 (2006-04-01), None
XP002461619 Database Caplus/Chemical Abstracts Service (HU191196), (1987).
XP002461620 Database Caplus/Chemical Abstracts Service (HU180705), (1983).
Kondo, et al., “Synthesis and Nucleophilic Ring-Opening Reactions of Activated Bicyclo-[3.1.0]Hexanes,” Tetrahedron Letters (1976) No. 49, pp. 4489-4492.
Kondo, et al., “A New Steroselective Synthesis of Prostaglandins,” Chem, Biochem, Pharmacol. Act. Prostanoids (1979), Pergamon; Oxford, Engl; Meeting Date 1978:185-193.
P. De Clercq, et al., “1H-NMR Spectral Parameters of Some 1,4-Dihydroxy-2,3-Dialkylcyclopentanes . . . ,” Bull. Soc. Chim. Belg. vol. 85/No. 11/1976, pp. 872-882.
P. De Clerq, et al., “Prostaglandin Synthesis Involving Catalytic Hydrogenation . . . ,” Tetrahedron (1976) vol. 32, pp. 2747-2752.
Stella, Valentino J, Expert Opinion of Therapeutic Patents, Prodrugs as therapeutics, 2004 14(3): 277-280.
Wolff et al. (Burger's Medicinal Chemistry, 5th Ed., vol. 1, pp. 975-977, 1994).
Testa, Bernard, Biochemical Pharmacology, Prodrug Research: futile or fertile? 68 (2004) 2097-2106.
Ettmayer, Peter, Medicinal Chemistry, Lessons Learned from Marketed and Investigational Prodrugs, 47(10) (2004) 2394-2404.
Ngo Vinh X.
Old David W.
Allergan Inc.
Barker Michael
Ene Doina G.
Forrestal Kevin J.
Saeed Kamal
LandOfFree
Therapeutic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2644818